| Literature DB >> 35131001 |
Abstract
In the present study, I explored the relationship between people's trust in different agents related to the prevention of the spread of coronavirus disease 2019 (COVID-19) and their compliance with pharmaceutical and non-pharmaceutical preventive measures. The COVIDiSTRESSII Global Survey dataset, which was collected from international samples, was analysed to examine the aforementioned relationship across different countries. For data-driven exploration, network analysis and Bayesian generalised linear model (GLM) analysis were performed. The result from network analysis demonstrated that trust in the scientific research community was most central in the network of trust and compliance. In addition, the outcome from Bayesian GLM analysis indicated that the same factor, trust in the scientific research community, was most fundamental in predicting participants' intent to comply with both pharmaceutical and non-pharmaceutical preventive measures. I briefly discussed the implications of the findings, the importance of trust in the scientific research community in explaining people's compliance with a measure to prevent the spread of COVID-19.Entities:
Keywords: Bayesian analysis; COVID-19; compliance; preventive measures; trust in science; vaccine
Mesh:
Year: 2022 PMID: 35131001 PMCID: PMC8886075 DOI: 10.1017/S0950268822000255
Source DB: PubMed Journal: Epidemiol Infect ISSN: 0950-2688 Impact factor: 2.451
Demographics of the whole dataset and each country
| Age | Gender | Education level | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Female | Male | Other/Would rather not say | Doctorate | University | University or equivalent | ⩽12 years | ⩽9 years | ⩽6 years | None | ||||
| All | 14 349 | 36.56 | 14.48 | 67.52% | 31.55% | 0.93% | 6.03% | 47.65% | 26.71% | 16.19% | 2.33% | 0.49% | 0.60% |
| Bolivia | 115 | 39.56 | 11.23 | 65.22% | 34.78% | 0.00% | 13.91% | 72.17% | 13.91% | 0.00% | 0.00% | 0.00% | 0.00% |
| Bosnia and Herzegovina | 109 | 39.85 | 11.51 | 76.15% | 23.85% | 0.00% | 13.89% | 65.74% | 7.41% | 12.04% | 0.00% | 0.93% | 0.00% |
| Brazil | 448 | 38.56 | 13.22 | 72.32% | 27.23% | 0.45% | 15.18% | 66.07% | 15.40% | 3.35% | 0.00% | 0.00% | 0.00% |
| Bulgaria | 299 | 41.47 | 16.74 | 73.58% | 25.75% | 0.67% | 6.04% | 50.67% | 32.55% | 10.40% | 0.00% | 0.00% | 0.34% |
| Colombia | 548 | 40.04 | 12.63 | 67.88% | 31.57% | 0.55% | 5.67% | 77.15% | 11.52% | 4.20% | 0.73% | 0.37% | 0.37% |
| Costa Rica | 270 | 35.92 | 10.37 | 69.63% | 29.26% | 1.11% | 1.11% | 78.15% | 14.81% | 3.70% | 1.85% | 0.37% | 0.00% |
| Czech Republic | 365 | 34.14 | 11.31 | 70.68% | 27.95% | 1.37% | 5.75% | 46.03% | 31.51% | 16.44% | 0.00% | 0.27% | 0.00% |
| Denmark | 127 | 42.30 | 10.59 | 61.42% | 38.58% | 0.00% | 11.81% | 57.48% | 23.62% | 2.36% | 1.57% | 3.15% | 0.00% |
| Ecuador | 291 | 31.78 | 10.80 | 66.32% | 32.99% | 0.69% | 2.75% | 69.76% | 22.68% | 3.44% | 0.69% | 0.34% | 0.34% |
| Estonia | 246 | 39.36 | 10.21 | 86.53% | 13.47% | 0.00% | 1.22% | 56.33% | 22.04% | 18.37% | 2.04% | 0.00% | 0.00% |
| Finland | 963 | 46.07 | 14.38 | 78.40% | 20.15% | 1.45% | 4.69% | 54.95% | 18.56% | 16.68% | 2.61% | 1.88% | 0.63% |
| Germany | 152 | 36.73 | 12.49 | 67.76% | 29.61% | 2.63% | 8.55% | 55.92% | 20.39% | 13.82% | 1.32% | 0.00% | 0.00% |
| Guatemala | 287 | 36.94 | 14.02 | 84.32% | 15.68% | 0.00% | 4.88% | 65.85% | 26.83% | 1.74% | 0.35% | 0.35% | 0.00% |
| Honduras | 429 | 25.86 | 8.13 | 66.90% | 32.17% | 0.93% | 1.40% | 20.05% | 62.00% | 14.22% | 0.93% | 0.70% | 0.70% |
| Ireland | 401 | 29.01 | 10.79 | 68.00% | 31.00% | 1.00% | 4.74% | 48.38% | 45.89% | 0.50% | 0.50% | 0.00% | 0.00% |
| Italy | 310 | 44.83 | 16.27 | 74.43% | 25.24% | 0.32% | 6.54% | 45.75% | 23.20% | 22.22% | 1.96% | 0.33% | 0.00% |
| Japan | 2133 | 45.49 | 11.08 | 41.87% | 56.96% | 1.17% | 1.03% | 31.77% | 20.84% | 36.46% | 6.34% | 0.84% | 2.72% |
| Kyrgyzstan | 254 | 32.44 | 12.46 | 82.28% | 14.96% | 2.76% | 2.77% | 52.57% | 14.23% | 27.67% | 2.77% | 0.00% | 0.00% |
| Lebanon | 141 | 29.31 | 12.24 | 73.05% | 26.24% | 0.71% | 6.43% | 43.57% | 37.86% | 9.29% | 2.14% | 0.71% | 0.00% |
| Malaysia | 225 | 27.22 | 8.83 | 69.33% | 28.44% | 2.22% | 4.44% | 53.78% | 39.11% | 2.67% | 0.00% | 0.00% | 0.00% |
| Norway | 376 | 40.86 | 13.58 | 80.32% | 19.68% | 0.00% | 8.24% | 61.17% | 18.35% | 9.57% | 1.06% | 0.80% | 0.80% |
| Pakistan | 157 | 24.33 | 6.54 | 97.45% | 2.55% | 0.00% | 8.92% | 45.22% | 38.22% | 7.01% | 0.64% | 0.00% | 0.00% |
| Portugal | 484 | 33.33 | 14.94 | 70.25% | 28.51% | 1.24% | 23.55% | 42.56% | 21.90% | 11.16% | 0.83% | 0.00% | 0.00% |
| Russian | 2260 | 26.05 | 10.49 | 70.93% | 28.14% | 0.93% | 0.66% | 28.98% | 46.70% | 19.58% | 3.54% | 0.31% | 0.22% |
| Slovakia | 313 | 34.49 | 13.64 | 88.82% | 10.86% | 0.32% | 8.09% | 49.19% | 26.21% | 13.92% | 0.97% | 0.97% | 0.65% |
| Spain | 575 | 40.44 | 13.83 | 64.52% | 34.96% | 0.52% | 20.70% | 53.91% | 21.39% | 3.30% | 0.70% | 0.00% | 0.00% |
| Sweden | 134 | 39.28 | 13.91 | 76.87% | 18.66% | 4.48% | 12.88% | 54.55% | 22.73% | 8.33% | 1.52% | 0.00% | 0.00% |
| Switzerland | 593 | 44.84 | 19.01 | 63.58% | 36.09% | 0.34% | 6.91% | 45.36% | 18.21% | 24.28% | 4.38% | 0.34% | 0.51% |
| Taiwan | 221 | 34.94 | 9.81 | 61.99% | 36.20% | 1.81% | 5.43% | 89.14% | 1.81% | 3.62% | 0.00% | 0.00% | 0.00% |
| Turkey | 200 | 23.79 | 8.26 | 68.50% | 30.50% | 1.00% | 3.00% | 34.50% | 4.50% | 57.50% | 0.00% | 0.00% | 0.50% |
| Uganda | 135 | 24.37 | 4.17 | 32.59% | 67.41% | 0.00% | 0.00% | 23.70% | 74.81% | 1.48% | 0.00% | 0.00% | 0.00% |
| Ukraine | 252 | 31.39 | 10.06 | 63.49% | 35.71% | 0.79% | 10.32% | 77.38% | 5.95% | 5.16% | 0.79% | 0.40% | 0.00% |
| United Kingdom | 134 | 36.58 | 12.88 | 76.12% | 22.39% | 1.49% | 28.36% | 52.99% | 11.19% | 6.72% | 0.75% | 0.00% | 0.00% |
| United States | 114 | 34.74 | 11.49 | 64.04% | 34.21% | 1.75% | 22.81% | 47.37% | 23.68% | 3.51% | 0.88% | 1.75% | 0.00% |
| Uruguay | 288 | 41.97 | 12.94 | 88.15% | 11.85% | 0.00% | 5.90% | 74.31% | 13.19% | 5.21% | 1.04% | 0.00% | 0.35% |
Fig. 1.Network plot. Solid line: positive edge weight. Dashed line: negative edge weight.
Fig. 2.Result from centrality analysis.
Results from Bayesian GLM analysis
| Trust 1 | Trust 2 | Trust 3 | Trust 4 | Trust 5 | Trust 6 | Trust 7 | log(Bayes Factor) vs. | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ES (ROPE %) | ES (ROPE %) | ES (ROPE %) | ES (ROPE %) | ES (ROPE %) | ES (ROPE %) | ES (ROPE %) | Null model (BFM0) | Full model (BFMF) | ||||||||
| Comp. 1 | 0.04 (0.01) | 0.06 (100.00%) | −0.04 (0.01) | −0.07 (100.00%) | −0.04 (0.01) | −0.06 (100.00%) | 0.08 (0.01) | 0.12 (99.63%) | 0.15 (0.01) | 0.25 (0.00%) | 0.05 (0.01) | 0.08 (100.00%) | 0.27 (0.01) | 0.46 (0.00%) | 1375.36 | |
| Comp. 2 | −0.03 (0.01) | −0.04 (100.00%) | 0.04 (0.01) | 0.06 (100.00%) | 0.07 (0.01) | 0.10 (100.00%) | 0.14 (0.01) | 0.25 (0.00%) | 256.86 | 5.91 | ||||||
| Comp. 3 | 0.03 (0.01) | 0.05 (100.00%) | 0.07 (0.01) | 0.11 (100.00%) | 0.04 (0.01) | 0.08 (100.00%) | 0.17 (0.01) | 0.28 (0.00%) | 480.29 | 5.57 | ||||||
| Comp. 4 | 0.06 (0.01) | 0.11 (100.00%) | 0.07 (0.01) | 0.12 (100.00%) | 0.11 (0.01) | 0.19 (9.10%) | 254.77 | 3.72 | ||||||||
| Comp. 5 | 0.07 (0.01) | 0.11 (100.00%) | 0.05 (0.01) | 0.09 (100.00%) | 0.10 (0.01) | 0.17 (30.44%) | 225.27 | 8.82 | ||||||||
| Comp. 6 | 0.06 (0.01) | 0.10 (100.00%) | 0.03 (0.01) | 0.05 (100.00%) | 0.09 (0.01) | 0.16 (74.11%) | 158.90 | 9.18 | ||||||||
| Comp. 7 | 0.07 (0.01) | 0.12 (100.00%) | 0.04 (0.01) | 0.07 (100.00%) | 0.11 (0.01) | 0.18 (24.57%) | 177.70 | 7.67 | ||||||||
| Comp. 8 | 0.06 (0.01) | 0.09 (100.00%) | 0.03 (0.01) | 0.05 (100.00%) | 0.13 (0.01) | 0.22 (0.00%) | 227.54 | 10.53 | ||||||||
Comp. 1 – Comp. 8: Compliance 1 – Compliance 8. β (s.e.): Standardised regression coefficient (standard error). ES (ROPE %): Effect size in Cohen's D (% of 95% HDI within the defined region of practical equivalence).